(Bloomberg) -- The US shortage of Pfizer Inc.’s drug that’s the optimal treatment for syphilis will likely extend at least into October as the country faces skyrocketing rates of the ...

“As the only manufacturer of penicillin G benzathine in the United States, Pfizer's inability to provide adequate quantities of Bicillin L-A has left the Food and Drug Administration, the ...